Skip to content
OpenCapital
Get started

Alkermes ALKS Change in receivables

Change in receivables at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$1.69B-11,147%

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's change in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's change in receivables?
Alkermes (ALKS) reported change in receivables of $23.22M in Q1 2026.
How has Alkermes's change in receivables changed year-over-year?
Alkermes's change in receivables increased by 135.3% year-over-year, from -$65.83M to $23.22M.
What does change in receivables mean?
The change in money owed to the company by its customers.
How do you interpret change in receivables?
A consistent increase may signal collection issues or aggressive revenue recognition policies.
How does change in receivables compare across companies?
Peers with similar commercialization models should show comparable days-sales-outstanding (DSO) metrics.